Supplementary Methods I: Detailed description of the study population
Diagram of examination cycles of the Rotterdam Study (RS). RS-I-1 refers to the baseline examination of the original cohort. RS-I-2, RS-I-3, RS-I-4, and RS-I-5 refer to re-examinations of the original cohort members. RS-II-1 refers to the extension of the cohort with persons from the study district that had become 55 years since the start of the study or those of 55 years or over that migrated into the study district. RS-II-2 and RS-II-3 refer to re-examinations of the extension cohort. RS-III-1 refers to the baseline examination of all persons aged 45 years and over living in the study district that had not been examined already (i.e., mainly comprising those aged 45-60 years). RS-III-2 refers to the first re-examination of this third cohort. Similarly, examinations RS-I-5, RS-II-3, and RS-III-2 share the same program items. 
Supplementary Methods II: details on the multiple imputation process
Variables (range missing values per variable: 0.02 to 10.79%) were imputed using multiple imputation under the fully conditioned specification to reduced bias due to missing data(1). Thirty imputed datasets were created using the R package mice (2) , and analysed separately. Results from these analyses were pooled using Rubin's rules in order to take into account the added uncertainty due to the missing data (3) . 
Multiple imputation

Population
For the imputation we used reliable and completed FFQs. In addition participants had to have less than 30% missing on study variables. Imputed population (n=4.754). Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: highdensity lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. Pooled data based on 30 imputations represent % for categorical variables and for continuous variables mean (SD) or median (P25-P75).*P-value is based on ANOVA, Kruskall-Wallis test or Chi-square test and is the comparison between the no NAFLD and NAFLD columns.
Supplementary
Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: highdensity lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: highdensity lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and logtransformed BMI Model 4 (metabolic + DQ) is in addition to the previous model adjusted for DQ.
HDL-C (mmol/L) 1.5 (0.4) 1.5 (0.4) 1.5 (0.4) 1.4 (0.4) <0.001 Triglycerides (mmol/L) 1.3 (1.0 -1.7) 1.2 (1.0 -1.7) 1.3 (1.0 -1.7) 1.3 (1.0 -1.8) 0
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. P-trend is calculated across the quartiles. Bold values indicate P<0.05. † Indicates significant values using P < 0.028 as determined by Sidák.
Model 1 (socio-demographic) is adjusted for age, education level, energy intake and study cohort Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and BMI Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ.
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. Bold values indicate P<0.05. † Indicates significant values using P < 0.028 as determined by Sidák.
Model 1 (socio-demographic) is adjusted for age, gender, education level and energy intake Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and BMI Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ. Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load.
RS-cohort I (n=1069)
PRAL n per quartile NEAP n per quartile A:P n per quartile Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. P-trend is calculated across the quartiles. Bold values indicate P<0.05. † Indicates significant values using P < 0.028 as determined by Sidák.
Q2
Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, diabetes mellitus and BMI Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ.
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. Model 1 (socio-demographic) is adjusted for gender, education level, energy intake and study cohort Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and BMI Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ.
Supplementary
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. P-trend is calculated across the quartiles.
Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in addition to the previous model adjusted for HDL-cholesterol, triglycerides metabolic syndrome, GFR and diabetes mellitus Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ.
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential renal acid load.
